Drugs / Quetiapine XR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00600756 | Jan 2008 → Oct 2009 | schizophrenia | AstraZeneca | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quetiapine XR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00600756 ↗ |
| Route | Oral | “Oral, once daily, tablets of 400 mg to 800 mg” NCT00600756 ↗ |